The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Seminar R1: Re-engineering drug preparation
Affiliation
Apotek Produktion & Laboratorier AB
Country
Sweden
1. Current Status, Position
Dr Sjökvist Saers is CEO at APL (Apotek Produktion & Laboratorier AB)
2. Education
- MSc Pharm, PhD Pharm, Uppsala university, Sweden
- Ass. Director / Director Department of Pharmaceutics, Astra Pain Control
- Global Project and Global Program Director of several projects, AstraZeneca
- Director Investigational Products, AstraZeneca
- Executive Director of Business Units, Apoteket AB
3. Research Area
- drug development
- preformulation/formulation
- manufacturing, stability studies
- clinical trials material
- compounding/extemporaneous preparations
- quality assurance
- business development
- contract development and manufacturing
- experience from senior management team and board of director of several companies and associations
- brand development